ArticleJAMA ophthalmology2019
Estimates of the Percentage of US Adults With Diabetes Who Could Be Screened for Diabetic Retinopathy in Primary Care Settings.
Article in JAMA ophthalmology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
28 citing papers in PubMed, 52 citations in OpenAlex.
- Impact of Prior Diabetic Retinal Screening on Hospitalization and Ophthalmic Follow-Up in Diabetic Patients with Newly Diagnosed Proliferative Diabetic Retinopathy.Diagnostics (Basel, Switzerland) · 2026Article
- 1. Improving Care and Promoting Health in Populations: Standards of Care in Diabetes-2026.Diabetes care · 2026Review
- Digital eyes on diabetes: a systematic review of attitudes toward telemedicine-based retinopathy screening.Oxford open digital health · 2026Article
- The association between estimated glucose disposal rate and self-reported diabetic retinopathy: evidence from two independent cohorts and machine learning.Frontiers in endocrinology · 2026Article
- Assessing and monitoring abnormal retinal blood circulation for early detection of pre-structural damage and enhanced diabetic retinopathy staging using non-invasive, high-resolution biophotonic imaging technology.Eye (London, England) · 2025Review
- Results of a New Virtual Program for Patients Overdue for Diabetic Retinopathy Evaluation.Ophthalmology and therapy · 2025Article
- Transforming retinal disease management through diabetes care.Journal of managed care & specialty pharmacy · 2025Article
- Comparison of diabetic retinopathy screening between hospital-based multidisciplinary and general practice-based settings: insights from a regional study in Italy.Acta diabetologica · 2025Observational
- Barriers and enablers of access to diabetes eye care in Auckland, New Zealand: a qualitative study.BMJ open · 2025Article
- 1. Improving Care and Promoting Health in Populations: Standards of Care in Diabetes-2025.Diabetes care · 2025Review
- The Role of Urban Residence, Race and Ethnicity, and Glycemic Control in Receiving Standards of Care and Progression to Vision-Threatening Diabetic Retinopathy.Diabetes care · 2025Article
- Factors Associated with Follow-Up Adherence After Teleophthalmology for Diabetic Eye Screening Before and During the COVID-19 Pandemic.Telemedicine journal and e-health : the official journal of the American Telemedicine Association · 2023Article
- Patient referral flow between physician and ophthalmologist visits for diabetic retinopathy screening among Japanese patients with diabetes: A retrospective cross-sectional cohort study using the National Database.Journal of diabetes investigation · 2023Article
- Perspectives of Latinx Patients with Diabetes on Teleophthalmology, Artificial Intelligence-Based Image Interpretation, and Virtual Care: A Qualitative Study.Telemedicine reports · 2023Article
- Patient and Provider Experience with Artificial Intelligence Screening Technology for Diabetic Retinopathy in a Rural Primary Care Setting.Journal of Maine Medical Center · 2023Article
- Effect of health system on the association of rurality and level of disadvantage with receipt of diabetic eye screening.BMJ open diabetes research & care · 2022Article
- A Framework for Augmented Intelligence in Allergy and Immunology Practice and Research-A Work Group Report of the AAAAI Health Informatics, Technology, and Education Committee.The journal of allergy and clinical immunology. In practice · 2022Article
- Ranked determinants of telemedicine diabetic retinopathy screening performance in the United States primary care safety-net setting: an exploratory CART analysis.BMC health services research · 2022Article
- Implementation of Teleophthalmology to Improve Diabetic Retinopathy Surveillance: Qualitative Interview Study of Clinical Staff Informed by Implementation Science Frameworks.JMIR diabetes · 2022Article
- Sustaining Gains in Diabetic Eye Screening: Outcomes from a Stakeholder-Based Implementation Program for Teleophthalmology in Primary Care.Telemedicine journal and e-health : the official journal of the American Telemedicine Association · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Importance: Prior studies found that screening for diabetic retinopathy (DR) in primary care settings using telemedicine increased screening rates among individuals with diabetes. This finding has led to interest in expanding the use of primary care-based screening for DR. Objective: To estimate the percentages of US adults with diabetes and high-risk US adults with diabetes who have regular contact with primary care physicians and therefore could potentially receive timely screening for DR in primary care settings. Design, Setting, and Participants: The empirical analyses used data from the cross-sectional population-based 2016 National Health Interview Survey on US adults 18 years or older with self-reported diabetes (n = 3229). Based on previous research, individuals who had lower income, lower educational levels, or type 2 diabetes; who were African American or Hispanic, uninsured, or not using insulin or oral medication for diabetes; or who did not have DR were defined as being at high risk of missing recommended eye examinations. Data were collected throughout 2016 and analyzed from July 17 through November 5, 2018. Main Outcomes and Measures: Outcomes were whether an individual visited a primary care physician and whether an individual missed having a dilated eye examination in the past year. Results: The survey sample included 3229 participants. Using weighted percentages of the full sample, 15.3% (95% CI, 13.8%-17.0%) had lower income, 19.7% (95% CI, 17.8%-21.6%) had lower educational levels, 15.4% (95% CI, 13.5%-17.4%) were African American, 16.0% (95% CI, 13.7%-18.6%) were Hispanic, 6.1% (95% CI, 4.9%-7.5%) were uninsured, and 50.1% (95% CI, 47.7%-52.4%) were female; the mean age was 60.1 years (95% CI, 59.4-60.8 years). In addition, 87.7% (95% CI, 85.9%-89.3%) visited a primary care physician in the past year. Of those who did not receive a dilated eye examination in the past year, 82.2% (95% CI, 78.4%-85.4%) visited a primary care physician during the year. Except for the uninsured subgroup, more than 78% of each high-risk subgroup had visited a primary care physician in the past year. Conclusions and Relevance: Screening for DR in primary care settings has the potential to provide timely screening to a large portion of US adults with diabetes because most US adults with diabetes, including those at high-risk of missing recommended eye examinations, have regular contact with primary care physicians.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.